The effects of nucleoside analogs on telomerase and telomeres in Tetrahymena.
The ribonucleoprotein enzyme telomerase is a specialized type of cellular reverse transcriptase which synthesizes one strand of telomeric DNA, using as the template a sequence in the RNA moiety of telomerase. We analyzed the effects of various nucleoside analogs, known to be chain-terminating inhibitors of retroviral reverse transcriptases, on Tetrahymena thermophila telomerase activity in vitro. We also analyzed the effects of such analogs on telomere length and maintenance in vivo, and on vegetative growth and mating of Tetrahymena cells. Arabinofuranyl-guanosine triphosphate (Ara-GTP) and ddGTP both efficiently inhibited telomerase activity in vitro, while azidothymidine triphosphate (AZT-TP), dideoxyinosine triphosphate (ddITP) or ddTTP were less efficient inhibitors. All of these nucleoside triphosphate analogs, however, produced analog-specific alterations of the normal banding patterns seen upon gel electrophoresis of the synthesis products of telomerase, suggesting that their chain terminating and/or competitive actions differ at different positions along the RNA template. The analogs AZT, 3'-deoxy-2',3'-didehydrothymidine (d4T) and Ara-G in nucleoside form caused consistent and rapid telomere shortening in vegetatively growing Tetrahymena. In contrast, ddG or ddI had no effect on telomere length or cell growth rates. AZT caused growth rates and viability to decrease in a fraction of cells, while Ara-G had no such effects even after several weeks in culture. Neither AZT, Ara-G, acycloguanosine (Acyclo-G), ddG nor ddI had any detectable effect on cell mating, as assayed by quantitation of the efficiency of formation of progeny from mated cells. However, AZT decreased the efficiency of programmed de novo telomere addition during macronuclear development in mating cells.
Strahl
C
C
Department of Microbiology and Immunology, University of California-San Francisco 94143-0414.
Blackburn
E H
EH
D000818:Animals; D001088:Arabinonucleotides / Q000494:pharmacology; D001483:Base Sequence; D002470:Cell Survival / Q000187:drug effects; D004253:DNA Nucleotidylexotransferase / Q000037:antagonists & inhibitors* / Q000378:metabolism; D003848:Deoxyguanine Nucleotides / Q000494:pharmacology; D054306:Dideoxynucleotides; D006160:Guanosine Triphosphate / Q000031:analogs & derivatives / Q000494:pharmacology; D008969:Molecular Sequence Data; D009711:Nucleotides / Q000494:pharmacology*; D016615:Telomere / Q000187:drug effects* / Q000502:physiology / Q000648:ultrastructure; D016808:Tetrahymena thermophila / Q000201:enzymology* / Q000235:genetics* / Q000502:physiology; D013942:Thymine Nucleotides / Q000494:pharmacology; D015215:Zidovudine / Q000031:analogs & derivatives / Q000494:pharmacology
D001088:Arabinonucleotides; D003848:Deoxyguanine Nucleotides; D054306:Dideoxynucleotides; D009711:Nucleotides; D013942:Thymine Nucleotides; D015215:Zidovudine; C031709:2',3'-dideoxyguanosine 5'-triphosphate; C052873:zidovudine triphosphate; C022206:9-beta-D-arabinofuranosylguanosine 5'-triphosphate; D006160:Guanosine Triphosphate; D004253:DNA Nucleotidylexotransferase; C017216:2',3'-dideoxythymidine triphosphate